Tectonic Therapeutic
TECX
45 hedge funds and large institutions have $14.8M invested in Tectonic Therapeutic in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 14 closing their positions.
0.7% less ownership
Funds ownership: 4.65% → 3.96% (-0.7%)
5% less capital invested
Capital invested by funds: $15.7M → $14.8M (-$859K)
17% less funds holding
Funds holding: 54 → 45 (-9)
47% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 15
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Natixis
Paris,
France
|
+$645K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$211K |
| 3 |
PFMU
Privium Fund Management (UK)
London,
United Kingdom
|
+$113K |
| 4 |
LPL Financial
San Diego,
California
|
+$89.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$51.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$1.76M |
| 2 |
Goldman Sachs
New York
|
-$511K |
| 3 |
BlackRock
New York
|
-$354K |
| 4 |
Renaissance Technologies
New York
|
-$264K |
| 5 |
GC
GMT Capital
Atlanta,
Georgia
|
-$135K |
TECX Hedge Fund Activity: Q4 2022 in Review
45 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q4 2022, worth a combined $14.8M — down 5.5% from $15.7M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of TECX and 5 opened new positions — a net loss of 9 holders — while 15 trimmed existing stakes and 8 added.
The largest buyer was Natixis, opening a new position worth an estimated $645K. The largest seller was K2 Principal Fund, exiting entirely with an estimated $1.76M sold.
- 45 institutional investors held Tectonic Therapeutic (TECX) as of Q4 2022, down from 54 in Q3 2022.
- Funds reported $14.8M of Tectonic Therapeutic stock for Q4 2022, down 5.5% quarter-over-quarter.
- 5 funds opened new Tectonic Therapeutic positions in Q4 2022 and 14 closed out, a net change of -9 holders.
- The largest Tectonic Therapeutic buyer in Q4 2022 was Natixis, an estimated $645K added.
- The largest Tectonic Therapeutic seller in Q4 2022 was K2 Principal Fund, an estimated $1.76M sold.
Based on aggregated 13F filings for Q4 2022.